Policy changes Backwork has recorded, newest first. The most recent change on record is from October 11, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
82,244 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 22, 2026 | Independence Blue Cross | Daratumumab (Darzalex), Daratumumab and Hyaluronidase-fihj (Darzalex Faspro) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Crovalimab-akkz (PiaSky) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Crizanlizumab-tmca (Adakveo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Collagenase clostridium histolyticum ( Xiaflex ), collagenase clostridium histolyticum-aaes (Qwo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Cobalamin (Vitamin B12), Folic Acid, and Homocysteine Testing | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Chimeric Antigen Receptor T-cell (CAR-T) Therapy: Carvykti and Abecma | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Chimeric Antigen Receptor (CART) Therapy: Yescarta Tecartus, Breyanzi, Kymriah and Aucatzyl | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Cetuximab (Erbitux) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Cemiplimab-rwlc (Libtayo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Carfilzomib (Kyprolis) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Canakinumab (Ilaris) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Burosumab-twza (Crysvita) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Brentuximab Vedotin (Adcetris) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Blinatumomab (Blincyto) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Bevacizumab (Avastin) and Related Biosimilars For Oncologic Use | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Belimumab (Benlysta) for Intravenous Use | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Belantamab mafodotin-blmf (Blenrep) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Axatilimab-csfr (Niktimvo) for Intravenous Use | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Avelumab (Bavencio) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Atezolizumab (Tecentriq) and Atezolizumab with Hyaluronidase-tqjs (Tecentriq Hybreza) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Asparaginase Erwinia Chrysanthemi (recombinant)-rywn (Rylaze) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Anifrolumab-fnia (Saphnelo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Amivantamab-vmjw (Rybrevant) and Amivantamab and hyaluronidase-lpuj (Rybrevant Faspro) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Alpha-1 Antitrypsin Therapy (e.g., Prolastin-C, Aralast NP, Glassia, Zemaira) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Alglucosidase alfa (e.g., Lumizyme), Avalglucosidase alfa-ngpt (Nexviazyme ), Cipaglucosidase alfa-atga (Pombiliti ) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Alemtuzumab (Lemtrada) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Agalsidase beta (Fabrazyme) and pegunigalsidase alfa-iwxj (Elfabrio) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Ado-Trastuzumab Emtansine (Kadcyla) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | ADAMTS13, recombinant-krhn (Adzynma) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Abatacept (Orencia) for Injection for Intravenous Use | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Zenocutuzumab-zbco (Bizengri) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Zanidatamab-hrii (Ziihera) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Velmanase alfa (Lamzede) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Vedolizumab (Entyvio) for Injection for Intravenous Use | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Ustekinumab for Intravenous Infusion | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Ublituximab-xiiy (Briumvi) for intravenous use | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Trilaciclib (Cosela) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Triamcinolone Acetonide Extended-Release Injectable (Zilretta) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Trastuzumab (Herceptin) and Related Biosimilars, Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Toripalimab-tpzi (Loqtorzi) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Tofersen (Qalsody) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Tisotumab vedotin-tftv (Tivdak) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Tislelizumab-jsgr (Tevimbra) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Tildrakizumab-asmn (Ilumya) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Teprotumumab-trbw (Tepezza) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Teplizumab-mzwv (Tzield) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Telisotuzumab vedotin-tllv (Emrelis) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Teclistamab-cqyv (Tecvayli) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Tebentafusp-tebn (Kimmtrak) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Tarlatamab-dlle (Imdelltra) for intravenous use | Codes changed |